Ordering patient medications is easy. With an online account, access our extensive formulary or over 40,000 unique items - 24 hours a day, 7 days a week.
Ordering your pet's prescription drugs from Wedgewood Pharmacy is safe, and convenient. With a prescription number, easily refill prescriptions and enroll in the AutoRefill Program.
Log in to browse, order and prescribe from our compounded drugs formulary.
Log in to fill, refill or renew the medication prescribed by your veterinarian.
NJ—Wedgewood Pharmacy has appointed
Kraus, CPA to the newly created role of chief financial officer of the
company. She reports to
Bliss, chief executive officer, who made the announcement.
Marcy A. Bliss, CEO of Wedgewood Pharmacy, noted, “Maria joins us with more
than 25 years of financial and operational experience in the pharmaceutical
services and technology industries. She has extensive experience working with
board of directors, private equity owners, and global teams. She brings the
substantial skills and experience we need to help guide our rapid growth.”
Prior to joining Wedgewood Pharmacy, she served in financial leadership
roles, most recently as CFO at Accelerated
Enrollment Solutions (AES), a unit of
PPD, a global patient-recruitment
and site network organization providing services to pharmaceutical companies
performing clinical trials. In this role, Maria was responsible for driving AES’
financial vision, as well as leading all financial operations, planning and
analysis, accounting, commercial budgets, and internal controls. She also served
on the financial leadership team of PPD.
Previously, she was executive vice president, Corporate Development and
Strategy at Bioclinica, where she was responsible for that company’s strategic
growth, including mergers and acquisitions. She was formerly vice president and
corporate controller at Bioclinica where she led the Global Accounting and
Finance, Legal, Procurement, Facilities, Human Resources, Marketing, and
Information Technology Departments. Maria began her career at
PricewaterhouseCoopers in Philadelphia.
Maria is a board director of The Hershey Trust Company and a board manager of
the Milton Hershey School, where she serves as vice chair, and chairs the Audit
Committee. She also is a board manager for the M.S. Hershey Foundation, and
serves as chairman. Maria also has been a board member with the Girl Scouts of
Eastern Pennsylvania for more than a decade.
Maria earned her B.S. degree in Accounting from Pennsylvania State University
and a certificate of Human Resources Management from Villanova University. She
is a certified public accountant.
Wedgewood Pharmacy is the largest compounding pharmacy devoted to
animal-health in the U.S. Compounding is the long-established tradition in
pharmacy practice that enables practitioners to prescribe and patients to take
medicines that are specially prepared by pharmacists to meet patients'
individual needs. A growing number of patients have unique health needs that
off-the-shelf prescription medicines cannot meet. For them, customized,
compounded medications prescribed or ordered by licensed physicians or
veterinarians and mixed safely by trained, licensed compounding pharmacists are
the only way to better health.
Compounded medications are created and prepared by specially trained
pharmacists and pharmacy technicians in state-regulated pharmacies when
mass-manufactured drugs are not, according to a prescriber, available or are not
appropriate for a patient. The company’s 503B
Outsourcing Facility, Wedgewood Connect, compounds medications under FDA’s
modified cGMP standards.
Today’s Wedgewood Pharmacy grew from a local community pharmacy to become one
of the largest compounding pharmacies in the United States. It is the leading
pharmacy brand in animal health, recognized by 99% of veterinarians, and used by
8 in 10 veterinarians within the past year. It also prepares compounded
medications for the human-health medical specialties of addiction medicine,
urology and ophthalmology. The company serves more than 50,000 prescribers and
hundreds of thousands of patients throughout the U.S. every year.
George (late) and Lucy Malmberg, both pharmacists, purchased Wedgewood
Pharmacy in 1981; the year after the pharmacy opened. In June 2016, New
Harbor Capital, became the majority shareholder of the company. In 2018, the
company acquired Diamondback Drugs. In 2020, the company purchased and began
production at Wedgewood Connect, an FDA-registered 503B Outsourcing Facility, in
San Jose, California. In the same year, the company acquired Wildlife
Pharmaceuticals and ZooPharm, in Colorado and Wyoming, respectively. In early
2021, New Harbor Capital sold its majority interest in the company to leading
global private-markets firm,
Partners Group, acting on behalf of its clients.
Wedgewood Pharmacy is accredited by the Pharmacy Compounding Accreditation
Board (PCAB®) for compliance with PCAB and other nationally recognized
compounding standards. PCAB was formed by eight of the nation’s leading pharmacy
associations and is a service of Accreditation Commission for Health Care. As a
third-party accreditation organization, PCAB has developed the highest national
standards against which providers are measured to demonstrate their ability to
effectively and efficiently deliver quality compounded medications to consumers.
Wedgewood Pharmacy employs more than 700 people.
Partners Group is a leading global private-markets firm. Since 1996, the firm
has invested more than USD 145 billion in private equity, private real estate,
private debt, and private infrastructure on behalf of its clients globally.
Partners Group seeks to generate superior returns through capitalizing on
thematic growth trends and transforming attractive businesses and assets into
market leaders. The firm is a committed, responsible investor and aims to create
sustainable returns with lasting, positive impact for all its stakeholders. With
more than USD 109 billion in assets under management as of December 31, 2020,
Partners Group provides an innovative range of bespoke client solutions to
institutional investors, sovereign wealth funds, family offices, and private
individuals globally. The firm employs more than 1,500 diverse professionals
across 20 offices worldwide and has regional headquarters in Baar-Zug,
Switzerland; Denver, USA; and Singapore. It has been listed on the SIX Swiss
Exchange since 2006 (symbol: PGHN). For more information, please visit
www.partnersgroup.com or follow the
company on LinkedIn
Marcy A. BlissChief Executive Officer
405 HERON DRIVE SUITE 200 • SWEDESBORO, NJ 08085-1749 | © 2004-2023 WEDGEWOOD PHARMACY, ALL RIGHTS RESERVED.
This content is intended for counseling purposes only. This content is informational/educational and is not intended to treat or diagnose any disease or patient. No claims are made as to the safety or efficacy of mentioned preparations. The compounded medications featured in this content have been prescribed and/or administered by prescribers who work with Wedgewood Pharmacy. You are encouraged to speak with your prescriber as to the appropriate use of any medication. Wedgewood Pharmacy’s compounded veterinary preparations are not intended for use in food and food-producing animals. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.